These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 9564642

  • 1. Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
    Ergür AR, Yergök YZ, Ertekin A, Küçük T, Müngen E, Tütüncü L.
    J Reprod Med; 1998 Mar; 43(3):185-90. PubMed ID: 9564642
    [Abstract] [Full Text] [Related]

  • 2. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.
    Tan SL, Farhi J, Homburg R, Jacobs HS.
    Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506
    [Abstract] [Full Text] [Related]

  • 3. [Treatment options of clomiphene-resistant polycystic ovary syndrome related infertility].
    Liang X, Zhuang G, Zhou C.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):591-3. PubMed ID: 11372407
    [Abstract] [Full Text] [Related]

  • 4. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
    Xi W, Liu S, Mao H, Yang Y, Xue X, Lu X.
    Drug Des Devel Ther; 2015 Oct; 9():6001-8. PubMed ID: 26648691
    [Abstract] [Full Text] [Related]

  • 5. The laparoscopic ovarian electrocautery versus gonadotropin therapy in infertile women with clomiphene citrate-resistant polycystic ovary syndrome; a randomized controlled trial.
    Mehrabian F, Eessaei F.
    J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S42-4. PubMed ID: 22768457
    [Abstract] [Full Text] [Related]

  • 6. The cycle characteristics of clomiphene with clomiphene and menotropins in polycystic ovary syndrome and non polycystic ovary syndrome infertile patients.
    Ghasemi M, Ashraf H, Koushyar H, Mousavifar N.
    Minerva Ginecol; 2013 Jun; 65(3):311-7. PubMed ID: 23689174
    [Abstract] [Full Text] [Related]

  • 7. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].
    Chen W, Zhang Y, Dai Q.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a new surgical approach for the treatment of clomiphene citrate-resistant infertility in polycystic ovary syndrome: laparoscopic ovarian multi-needle intervention.
    Kaya H, Sezik M, Ozkaya O.
    J Minim Invasive Gynecol; 2005 Oct; 12(4):355-8. PubMed ID: 16036198
    [Abstract] [Full Text] [Related]

  • 9. Ovulatory disorders in women with polycystic ovary syndrome.
    Franks S, Adams J, Mason H, Polson D.
    Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
    [Abstract] [Full Text] [Related]

  • 10. Induction of ovulation in the patient with polycystic ovarian disease.
    Blankstein J, Quigley MM.
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):733-49. PubMed ID: 3143566
    [Abstract] [Full Text] [Related]

  • 11. [Continuous pulsatile subcutaneous gonadotropin stimulation in polycystic ovary syndrome: a therapeutic alternative].
    Steck T, Würfel W, Witteler M, Albert P.
    Geburtshilfe Frauenheilkd; 1991 May; 51(5):373-8. PubMed ID: 1907938
    [Abstract] [Full Text] [Related]

  • 12. Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients.
    Hosseini MA, Aleyasin A, Saeedi H, Mahdavi A.
    J Obstet Gynaecol Res; 2010 Jun; 36(3):605-10. PubMed ID: 20598044
    [Abstract] [Full Text] [Related]

  • 13. [Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].
    Chen Y, Zhang D.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):874-877. PubMed ID: 28598116
    [Abstract] [Full Text] [Related]

  • 14. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME, Alborzi S, Jahromi BN.
    Int J Fertil Womens Med; 2002 Nov; 47(6):272-7. PubMed ID: 12570169
    [Abstract] [Full Text] [Related]

  • 15. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N, Persico P, Di Sebastiano F, Marsiglio E, Ferrari A.
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [Abstract] [Full Text] [Related]

  • 16. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
    Shi YH, Sheng Y, Chen ZJ, Yan JH, Gao Q, Liu H, Ma ZX.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
    [Abstract] [Full Text] [Related]

  • 17. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
    Blumenfeld Z, Lang N, Amit A, Kahana L, Yoffe N.
    Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
    [Abstract] [Full Text] [Related]

  • 18. Ovulation induction with gonadotropins in women with polycystic ovary disease.
    Kupferminc MJ, Lessing JB, Peyser MR.
    J Reprod Med; 1991 Jan; 36(1):61-4. PubMed ID: 1901089
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study.
    Li C, Cheng J, Wang J, Xue Y, Huang Z, Zhang S, Lv J.
    Arch Gynecol Obstet; 2011 Sep; 284(3):757-64. PubMed ID: 21614496
    [Abstract] [Full Text] [Related]

  • 20. Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients.
    Tehraninejad ES, Nasiri R, Rashidi B, Haghollahi F, Ataie M.
    Arch Gynecol Obstet; 2010 Sep; 282(3):319-25. PubMed ID: 20379731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.